Learn

Scientific posters, manuscripts and webinars

Peer-reviewed publications and conference posters authored by our dedicated team of
oncologists, pathologists and scientists.

Webinar  -  5 March 2025

The Impact of Prior Single-Gene Testing on Comprehensive Genomic Profiling Results, Practical Considerations for Personalized Cancer Care

Read Moreabout The Impact of Prior Single-Gene Testing on Comprehensive Genomic Profiling Results, Practical Considerations for Personalized Cancer Care

Peer-Reviewed Publication  -  2 March 2025

From tissue-specific to tissue-agnostic: HER2 overexpression and the rise of antibody-drug conjugates

Read Moreabout From tissue-specific to tissue-agnostic: HER2 overexpression and the rise of antibody-drug conjugates

Article  -  27 February 2025

Graphical Summary: A consensus-based classification workflow to determine genetically inferred ancestry from comprehensive genomic profiling of patients with solid tumors

Read Moreabout Graphical Summary: A consensus-based classification workflow to determine genetically inferred ancestry from comprehensive genomic profiling of patients with solid tumors

Webinar  -  5 February 2025

Molecular Tumor Board: 47-year-old male with papillary thyroid cancer and BRAF V600E alteration

Read Moreabout Molecular Tumor Board: 47-year-old male with papillary thyroid cancer and BRAF V600E alteration

Peer-Reviewed Publication  -  14 January 2025

Analytical Validation of the Labcorp Plasma Complete Test, a Cell-Free DNA Comprehensive Genomic Profiling Tool for Precision Oncology

Read Moreabout Analytical Validation of the Labcorp Plasma Complete Test, a Cell-Free DNA Comprehensive Genomic Profiling Tool for Precision Oncology

Article  -  9 January 2025

Graphical Summary: Comprehensive assessment of immune phenotype and its effects on survival outcomes in HER2-low versus HER2-zero breast cancer

Read Moreabout Graphical Summary: Comprehensive assessment of immune phenotype and its effects on survival outcomes in HER2-low versus HER2-zero breast cancer

Webinar  -  6 December 2024

Molecular Tumor Board: 82-year-old female with high grade ovarian serous adenocarcinoma and BRCA1 F709fs mutation

Read Moreabout Molecular Tumor Board: 82-year-old female with high grade ovarian serous adenocarcinoma and BRCA1 F709fs mutation

Article  -  6 December 2024

Graphical Summary: Comprehensive NGS profiling to enable detection of ALK gene rearrangements and MET amplifications in non-small cell lung cancer

Read Moreabout Graphical Summary: Comprehensive NGS profiling to enable detection of ALK gene rearrangements and MET amplifications in non-small cell lung cancer

Webinar  -  6 December 2024

Molecular Tumor Board: 38-year-old female with follicular thyroid cancer and NRAS Q61R alteration

Read Moreabout Molecular Tumor Board: 38-year-old female with follicular thyroid cancer and NRAS Q61R alteration